DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 2.10% to $493.22 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.03% to 6,000.36 and the Dow Jones Industrial Average rising 1.05% to 42,762.87.
The stock's rise snapped a three-day losing streak.
Regeneron Pharmaceuticals Inc. closed 59.28% below its 52-week high of $1,211.20, which the company reached on August 27th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc. $(AMGN)$ rose 1.13% to $290.33, Moderna Inc. (MRNA) rose 5.13% to $27.46, and Gilead Sciences Inc. $(GILD)$ rose 1.81% to $112.46.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled June 6, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
June 06, 2025 16:48 ET (20:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.